News


EmulTech news
EmulTech announces new project
September 12, 2011EmulTech announces today that it has signed a feasibility agreement with a top-10 biopharmaceutical company to develop innovative drug particle formulation.
Under the contract announced today, EmulTech will develop innovative drug particle formulation of an undisclosed compound. If the evaluation is successful, the contract may progress to a full process development, manufacturing and licensing agreement. Financial terms of the current agreement are not disclosed.